glp 1 and addiction treatment GLP-1 medications are getting attention for their potential in care. Here's what the research is finding. #AddictionTreatment #GLP1 #EmergingResearch GLP-1 Treatment Associated with a

Postprandial active GLP-1 was increased at 5% WL (P<0.01) and CCK reduced at 5 and 10% WL (P<0.01, for both) and wk 9 (P<0.001)

Results Patients with a high cumulative dose of GLP-1 agonist are associated with a higher risk of developing drug-induced pancreatitis associated with GLP-1 agonists, indicated by a statistically significant odds ratio

This systematic review and meta-analysis evaluates the durability of these therapeutic benefits following treatment discontinuation

Charles Barkley lost 50 pounds with GLP-1, stopped treatment, gained back 70 pounds, and now he's being paid millions to tell other men to take it

for example, weight loss associated with the use of GLP-1 RAs in people without cancer may be associated with the prevention of obesity-related cancers